FEBS Letters · 1984 · 115 citations · 15 references
Human Glucagon‐likePancreatic GlucagonCellular PhysiologyGastrointestinal Peptide HormonePituitary GlandNeuroendocrine MechanismHypothalamic PeptideNeurochemistryMolecular PhysiologyBiochemistryG Protein-coupled ReceptorNeuropharmacologyNervous SystemEndocrinologyPharmacologyHuman Glucagon-like PeptidesSignal TransductionNatural SciencesPhysiologyNeuroscienceMolecular NeurobiologyCellular BiochemistryMedicinePreproglucagon GeneNeuropeptides
Two human glucagon-like peptides, GLP-1 and GLP-2, which are coencoded with pancreatic glucagon in the preproglucagon gene, do not significantly inhibit [125I]monoiodoglucagon binding to rat liver and brain membranes and do not activate adenylate cyclase in liver plasma membranes. Nevertheless, GLP-1 and GLP-2 were each found to be potent stimulators of both rat hypothalamic and pituitary adenylate cyclase. Only 30-50 pM concentrations of each peptide elicited half-maximal adenylate cyclase stimulation. Our data suggest that GLP-1 and GLP-2 may be neurotransmitters and/or neuroendocrine effectors, which would account for their high degree of sequence conservation through vertebrate evolution.
15
Exon duplication and divergence in the human preproglucagon gene
Graeme I. Bell, Ray Sánchez-Pescador, Paul J. Laybourn et al. · Nature · 1983 · 584 citations
Roger H. Unger, Lelio Orci · New England Journal of Medicine · 1981 · 298 citations